Please login to the form below

Not currently logged in
Email:
Password:

EUSA Pharma appoints Rolf Hoffmann to its board

He most recently worked at Amgen for over a decade

Roff HoffmannOncology-focused pharmaceutical group EUSA Pharma has added to its board of directors in the form of Rolf Hoffman.

Hoffman, who is currently chairman of Biotest and sits on the board of directors of Genmab, brings over 30 years’ pharmaceutical experience to his new position having served in a number of senior roles in the industry.

He most recently spent 12 years with Amgen as its senior vice president of commercial operations, US and prior to that, he worked for SVP.

Hoffman said: “I have watched EUSA Pharma’s remarkable progress in the three years since it was founded, and am delighted to now help the company achieve its ambitious plans.”

His new role will see him play a role in guiding EUSA’s commercial strategy for its cancer treatments.

Bryan Morton, executive chairman at EUSA Pharma, said: “Rolf’s strategic insight and guidance, based on significant commercial experience in the oncology field will prove invaluable as EUSA launches Qarziba and Fotivda in Europe.”

8th March 2018

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics